Literature DB >> 9692912

Mechanisms of melanogenesis inhibition by tumor necrosis factor-alpha in B16/F10 mouse melanoma cells.

M Martínez-Esparza1, C Jiménez-Cervantes, F Solano, J A Lozano, J C García-Borrón.   

Abstract

The inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) is present in the dermal and epidermal layers of normal skin [Kilgus, O., Payer, E., Schreiber, S., Elbe, A., Strohal, R. & Stingl, G. (1993) J. Invest. Dermatol. 100, 674-680]. Its local concentrations are modified by several stimuli, including wound healing and ultraviolet irradiation. Moreover, TNF-alpha inhibits melanogenesis in normal melanocytes [Swope, V., Abdel-Malek, Z., Kassem, L. & Norlund, J. (1991) J. Invest. Dermatol. 96, 180-185], and is, therefore, a potential autocrine/paracrine regulator of pigmentation. We have analyzed the mechanisms of this effect using B16/F10 melanoma cells as a model. Nanomolar concentrations of TNF-alpha inhibit the tyrosine hydroxylase and dopa oxidase activities of B16/F10 melanocytes, to less than 30% control levels, without effects on tyrosinase-related protein 2/dopachrome tautomerase (TRP2/DCT). The 50% inhibition was obtained at 1 nM TNF-alpha and 48 h treatment. The effect of TNF-alpha was noticeable after 6 h treatment, and maximal after 24 h. This inhibition is explained by decreased intracellular levels of tyrosinase and tyrosinase-related protein 1 (TRP1), but not of TRP2/DCT as detected by Western blotting. Northern-blot experiments showed that the inhibitory effect is partially explained by a reduced accumulation of the corresponding mRNAs, that dropped to about 50% of control values (48 h treatment, 5 nM TNF-alpha). Moreover, the tyrosine hydroxylase and dopa oxidase activities decreased more rapidly in TNF-alpha-treated cells than in control cells, under conditions of inhibition of protein synthesis. This suggests a TNF-mediated reduction of tyrosinase half-life. However, the possibility of an inhibitory post-translational modification of the enzyme induced by TNF cannot be ruled out. Therefore, the inhibitory effect of TNF-alpha on tyrosinase and TRP-1 results from combined effect on mRNA levels and enzymatic activity or protein stability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692912     DOI: 10.1046/j.1432-1327.1998.2550139.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  16 in total

1.  Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice.

Authors:  Yushu Joy Xie; Michael Dougan; Noor Jailkhani; Jessica Ingram; Tao Fang; Laura Kummer; Noor Momin; Novalia Pishesha; Steffen Rickelt; Richard O Hynes; Hidde Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-01       Impact factor: 11.205

2.  UV-B radiation induces macrophage migration inhibitory factor-mediated melanogenesis through activation of protease-activated receptor-2 and stem cell factor in keratinocytes.

Authors:  Akiko Enomoto; Yoko Yoshihisa; Takako Yamakoshi; Mati Ur Rehman; Osamu Norisugi; Hiroshi Hara; Kenji Matsunaga; Teruhiko Makino; Jun Nishihira; Tadamichi Shimizu
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo.

Authors:  Oscar Alcazar; Susan Achberger; Wayne Aldrich; Zhenbo Hu; Soledad Negrotto; Yogen Saunthararajah; Pierre Triozzi
Journal:  Int J Cancer       Date:  2011-09-06       Impact factor: 7.396

Review 4.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

5.  The melanogenesis-inhibitory effect and the percutaneous formulation of ginsenoside Rb1.

Authors:  Lin Wang; Ai-Ping Lu; Zhi-Ling Yu; Ricky N S Wong; Zhao-Xiang Bian; Hoi-Hin Kwok; Patrick Ying-Kit Yue; Li-Min Zhou; HuBiao Chen; Min Xu; Zhijun Yang
Journal:  AAPS PharmSciTech       Date:  2014-06-04       Impact factor: 3.246

6.  Molecular markers in patients with chronic wounds to guide surgical debridement.

Authors:  Harold Brem; Olivera Stojadinovic; Robert F Diegelmann; Hyacinth Entero; Brian Lee; Irena Pastar; Michael Golinko; Harvey Rosenberg; Marjana Tomic-Canic
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

7.  Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Amina R Gani; Mohmmad Shoab Mansuri; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

Review 8.  Role of the ubiquitin proteasome system in regulating skin pigmentation.

Authors:  Hideya Ando; Masamitsu Ichihashi; Vincent J Hearing
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

9.  Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.

Authors:  Naresh C Laddha; Mitesh Dwivedi; Rasheedunnisa Begum
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 10.  Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention.

Authors:  Michele Manganelli; Stefania Guida; Anna Ferretta; Giovanni Pellacani; Letizia Porcelli; Amalia Azzariti; Gabriella Guida
Journal:  Genes (Basel)       Date:  2021-07-19       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.